Key facts
- This page summarizes Kevin Michael Donahue's Form 4/A - Amendment filing for MAINZ BIOMED N.V. (MYNZ).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 20 Jan 2026, 10:29.
Kevin Michael Donahue - 17 Oct 2025 Form 4/A - Amendment Insider Report for MAINZ BIOMED N.V. (MYNZ)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- MYNZ
- Reported as of
- 17 Oct 2025
- Net transaction value
- +$1,034,350
- SEC form
- 4/A - Amendment
- Accepted by SEC
- 20 Jan 2026, 10:29:36 UTC
- Original report date
- 16 Jan 2026
- Source filing
- View source filing
- Reporting owner signature
- Kevin Donahue
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Kevin Michael Donahue filed Form 4/A - Amendment for MAINZ BIOMED N.V. (MYNZ) on 20 Jan 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$1,034,350.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.
Reporting Owners (1)
CIK 0002105585
Primary reporting owner
Donahue Kevin Michael
- Relationship
- 10%+ Owner
- Address
- 2502 KIRBY STREET, DALLAS
- Signature
- Kevin Donahue
- Signature date
- 20 Jan 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MYNZ
transaction
Common Stock
Purchase
- Transaction value
- $1,034,350
- Shares
- +685,000
- Change %
- Price
- $1.51
- Shares after
- 685,000
- Date
- 17 Oct 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
Correction to Form 4 filed on 1/16/2026